PFE是好的long term investment

sp500

辉瑞是一项好的长期投资[color=rgba(0, 0, 0, 0.3)][backcolor=rgba(0, 0, 0, 0.05)]Original [color=rgba(0, 0, 0, 0.3)]乔什·内森-卡吉斯 [url=]巴伦周刊 [/url] [color=rgba(0, 0, 0, 0.3)]2021-11-22

在令人印象深刻的研发能力的推动下，辉瑞股价将迎来上涨。

11月8日清晨《巴伦周刊》通过电话联系到辉瑞(PFE)首席科学官迈克尔·多尔斯滕(Mikael Dolsten)时，他的声音听起来好像心情不错的样子。就在几天前，辉瑞发布消息称，其抗新冠病毒药物把高危成年人的住院风险降低了89%。这一消息震惊了市场。“在打破世界纪录的同时又获得一个大满贯，这种事可不常发生，”多尔斯滕说，他指的是辉瑞的两大胜利：在仅仅10个月的时间里研制出效力惊人的新冠疫苗，一年后又研制出同样效力惊人的抗新冠病毒药。

sp500

"Morgan Stanley analyst Matthew Harrison raised the firm's price target on Pfizer (PFE) to $60 from $50 and keeps an Equal Weight rating on the shares as the new COVID variant Omicron highlights the continued variant risk in an evolving pandemic. The analyst believes mRNA vaccines, certain antibody therapies and Pfizer's oral are most likely to benefit. Both Merck (MRK) and Pfizer will sell what they can make, but Pfizer's oral will likely be preferred given the more limited impact from the full Merck data and concerns around the profile of the drug, Harrison contends".

sp500

PFE will soon get above 60/share

sp500

NYC Vaccine Requirement for Kids Age 5-11 Starts Next Week: What to Know
The mandate deadline for children 5-11 is Dec. 14, while kids age 12-17 will soon have to provide proof of a double dose of COVID vaccination
Published December 6, 2021 • Updated on December 6, 2021 at 2:47 pm